共 100 条
[1]
AlOmeir OA-O(2020)Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory Support Care Cancer 28 5075-5084
[2]
Patel NA-O(2015)Breast cancer survivorship: where are we today? Adv Exp Med Biol 862 1-8
[3]
Donyai PA-O(2015)A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer Breast Cancer Res Treat 151 27-40
[4]
Ganz PA(2016)Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis JAMA Oncol 2 1477-1486
[5]
Goodwin PJ(2010)American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer J Clin Oncol 28 3784-3796
[6]
Diaby V(1998)Tamoxifen for early breast cancer: an overview of the randomised trials. Early breast cancer trialists' collaborative group Lancet 351 1451-1467
[7]
Tawk R(2012)Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review Breast Cancer Res Treat 134 459-478
[8]
Sanogo V(2017)Association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy adherence among medicare patients with breast cancer J Clin Oncol 35 86-95
[9]
Xiao H(2018)The association between out-of-pocket costs and adherence to adjuvant endocrine therapy among newly diagnosed breast cancer patients Am J Clin Oncol 41 708-715
[10]
Montero AJ(2019)The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer Cancer 125 374-381